









Markets
/
Stocks
/
nasdaq-verv
/

Verve Therapeutics Inc

VERV

11.130USD

+0.030+0.27%

Market hours （ET）Quotes delayed by 15 min

988.31MMarket Cap

LossP/E TTM



Verve Therapeutics Inc

11.130

+0.030+0.27%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

479.03%32.98M

154.28%13.08M

120.24%6.87M

219.73%6.69M

305.63%5.70M

408.30%5.14M

235.52%3.12M

--2.09M

--1.40M

--1.01M

--929.00K

----

Revenue

479.03%32.98M

154.28%13.08M

120.24%6.87M

219.73%6.69M

305.63%5.70M

408.30%5.14M

235.52%3.12M

--2.09M

--1.40M

--1.01M

--929.00K

----

Operating expenses

11.31%69.61M

17.02%69.15M

15.01%63.77M

8.00%65.53M

4.82%62.54M

21.28%59.09M

23.80%55.45M

43.81%60.68M

86.88%59.66M

49.73%48.72M

90.58%44.79M

148.71%42.19M

127.05%31.93M

84.89%32.54M

161.95%23.50M

153.72%16.96M

90.81%14.06M

--17.60M

--8.97M

--6.69M

--7.37M

R&D expenses

12.57%54.46M

17.60%55.05M

14.10%49.94M

7.88%50.98M

2.69%48.38M

25.55%46.81M

24.34%43.77M

42.67%47.26M

92.36%47.11M

43.74%37.28M

101.18%35.20M

146.78%33.13M

115.87%24.49M

66.53%25.94M

129.65%17.50M

137.41%13.42M

73.92%11.35M

--15.58M

--7.62M

--5.65M

--6.52M

Depreciation, depletion, and amortization

5.15%1.72M

12.06%1.70M

19.00%1.75M

24.68%1.67M

44.81%1.63M

64.00%1.52M

105.58%1.47M

106.33%1.34M

119.26%1.13M

95.97%925.00K

74.03%717.00K

62.00%648.00K

74.83%514.00K

86.56%472.00K

-33.97%412.00K

33.33%400.00K

78.18%294.00K

--253.00K

--624.00K

--300.00K

--165.00K

Operating profit

35.55%-36.64M

-3.93%-56.07M

-8.74%-56.91M

-0.44%-58.84M

2.43%-56.84M

-13.07%-53.95M

-19.32%-52.33M

-38.85%-58.58M

-82.49%-58.26M

-46.62%-47.71M

-86.62%-43.86M

-148.71%-42.19M

-127.05%-31.93M

-84.89%-32.54M

-161.95%-23.50M

-153.72%-16.96M

-90.81%-14.06M

---17.60M

---8.97M

---6.69M

---7.37M

Net non-operating interest income (expenses)

Non-operating interest income

-32.90%5.46M

-0.49%6.31M

17.91%6.89M

36.61%7.43M

46.70%8.14M

40.88%6.34M

195.60%5.84M

1665.58%5.44M

6663.41%5.55M

6932.81%4.50M

3628.30%1.98M

6060.00%308.00K

310.00%82.00K

--64.00K

43.24%53.00K

-90.00%5.00K

-74.03%20.00K

----

--37.00K

--50.00K

--77.00K

Non-operating interest expense

----

--2.00K

----

Special income (expenses)

185.90%223.00K

71.25%-205.00K

-100.75%-6.00K

352.42%1.67M

-89.43%78.00K

-132.75%-713.00K

124.26%802.00K

-170.58%-662.00K

-55.99%738.00K

91.13%2.18M

-572.29%-3.31M

102.61%938.00K

115.55%1.68M

119.21%1.14M

1372.73%700.00K

-3714.19%-36.01M

-53.94%778.00K

---5.93M

---55.00K

---944.00K

--1.69M

Income before tax

36.35%-30.95M

-3.40%-49.96M

-9.49%-50.03M

7.56%-49.74M

6.44%-48.63M

-17.76%-48.32M

-1.11%-45.69M

-31.41%-53.81M

-72.30%-51.98M

-30.94%-41.03M

-98.65%-45.19M

22.69%-40.95M

-127.44%-30.17M

-33.17%-31.34M

-153.05%-22.75M

-598.75%-52.97M

-136.71%-13.26M

---23.53M

---8.99M

---7.58M

---5.60M

Income tax

-25.47%79.00K

128.13%73.00K

55.22%104.00K

-62.50%66.00K

--106.00K

-39.62%32.00K

--67.00K

--176.00K

----

--53.00K

----

Income after tax

36.32%-31.03M

-3.48%-50.03M

-9.56%-50.13M

7.74%-49.80M

6.23%-48.74M

-17.69%-48.35M

-1.26%-45.76M

-31.84%-53.98M

-72.30%-51.98M

-31.11%-41.09M

-98.65%-45.19M

22.69%-40.95M

-127.44%-30.17M

-33.17%-31.34M

-153.05%-22.75M

-598.75%-52.97M

-136.71%-13.26M

---23.53M

---8.99M

---7.58M

---5.60M

Net income from continuous operations

36.32%-31.03M

-3.48%-50.03M

-9.56%-50.13M

7.74%-49.80M

6.23%-48.74M

-17.69%-48.35M

-1.26%-45.76M

-31.84%-53.98M

-72.30%-51.98M

-31.11%-41.09M

-98.65%-45.19M

22.69%-40.95M

-127.44%-30.17M

-33.17%-31.34M

-153.05%-22.75M

-598.75%-52.97M

-136.71%-13.26M

---23.53M

---8.99M

---7.58M

---5.60M

Net income attributable to controlling interests

36.32%-31.03M

-3.48%-50.03M

-9.56%-50.13M

7.74%-49.80M

6.23%-48.74M

-17.69%-48.35M

-1.26%-45.76M

-31.84%-53.98M

-72.30%-51.98M

-31.11%-41.09M

-98.65%-45.19M

22.69%-40.95M

-127.44%-30.17M

-33.17%-31.34M

-153.05%-22.75M

-598.75%-52.97M

-136.71%-13.26M

---23.53M

---8.99M

---7.58M

---5.60M

Net income attributable to common shareholders

36.32%-31.03M

-3.48%-50.03M

-9.56%-50.13M

7.74%-49.80M

6.23%-48.74M

-17.69%-48.35M

-1.26%-45.76M

-31.84%-53.98M

-72.30%-51.98M

-31.11%-41.09M

-98.65%-45.19M

22.69%-40.95M

-127.44%-30.17M

-33.17%-31.34M

-153.05%-22.75M

-598.75%-52.97M

-136.71%-13.26M

---23.53M

---8.99M

---7.58M

---5.60M

Basic earnings per share

40.38%-0.35

16.95%-0.58

18.17%-0.59

32.14%-0.59

30.31%-0.59

-3.87%-0.69

8.36%-0.72

-3.58%-0.87

-35.44%-0.84

-3.34%-0.67

-66.96%-0.79

23.85%-0.84

-115.92%-0.62

-26.58%-0.65

-142.67%-0.47

-571.98%-1.10

-136.72%-0.29

---0.51

---0.19

---0.16

---0.12

Diluted earnings per share

40.38%-0.35

16.95%-0.58

18.17%-0.59

32.14%-0.59

30.31%-0.59

-3.87%-0.69

8.36%-0.72

-3.58%-0.87

-35.44%-0.84

-3.34%-0.67

-66.96%-0.79

23.85%-0.84

-115.92%-0.62

-26.58%-0.65

-142.67%-0.47

-571.98%-1.10

-136.72%-0.29

---0.51

---0.19

---0.16

---0.12

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

